144 related articles for article (PubMed ID: 20171144)
1. Lacosamide intoxication in attempted suicide.
Bauer S; David Rudd G; Mylius V; Hamer HM; Rosenow F
Epilepsy Behav; 2010 Apr; 17(4):549-51. PubMed ID: 20171144
[TBL] [Abstract][Full Text] [Related]
2. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
Harris JA; Murphy JA
Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
[TBL] [Abstract][Full Text] [Related]
3. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures.
Krauss G; Ben-Menachem E; Mameniskiene R; Vaiciene-Magistris N; Brock M; Whitesides JG; Johnson ME;
Epilepsia; 2010 Jun; 51(6):951-7. PubMed ID: 20041945
[TBL] [Abstract][Full Text] [Related]
4. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
Beydoun A; D'Souza J; Hebert D; Doty P
Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
[TBL] [Abstract][Full Text] [Related]
6. Minimizing pharmacodynamic interactions of high doses of lacosamide.
Edwards HB; Cole AG; Griffiths AS; Lin B; Bean A; Krauss GL
Acta Neurol Scand; 2012 Apr; 125(4):228-33. PubMed ID: 22070525
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy.
Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS
Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
Tilz C; Resch R; Hofer T; Eggers C
Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
[TBL] [Abstract][Full Text] [Related]
10. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
Errington AC; Stöhr T; Heers C; Lees G
Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy.
Gavatha M; Ioannou I; Papavasiliou AS
Epilepsy Behav; 2011 Apr; 20(4):691-3. PubMed ID: 21406334
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?
Novy J; Patsalos PN; Sander JW; Sisodiya SM
Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937
[TBL] [Abstract][Full Text] [Related]
13. Cardiac sodium channel blockade after an intentional ingestion of lacosamide, cyclobenzaprine, and levetiracetam: Case report.
Chua-Tuan JL; Cao D; Iwanicki JL; Hoyte CO
Clin Toxicol (Phila); 2015 Jul; 53(6):565-8. PubMed ID: 25951877
[TBL] [Abstract][Full Text] [Related]
14. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy.
Heyman E; Lahat E; Levin N; Berkovitch M; Gandelman-Marton R
Eur J Paediatr Neurol; 2012 Jan; 16(1):15-9. PubMed ID: 21924653
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre.
Kamel JT; DeGruyter MA; D'Souza WJ; Cook MJ
Acta Neurol Scand; 2013 Mar; 127(3):149-53. PubMed ID: 22845761
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide, a newer antiepileptic.
Patyar S; Medhi B
Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
[TBL] [Abstract][Full Text] [Related]
17. Moderate toxic effects following acute zonisamide overdose.
Hofer KE; Trachsel C; Rauber-Lüthy C; Kupferschmidt H; Kullak-Ublick GA; Ceschi A
Epilepsy Behav; 2011 May; 21(1):91-3. PubMed ID: 21463969
[TBL] [Abstract][Full Text] [Related]
18. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats.
Brandt C; Heile A; Potschka H; Stoehr T; Löscher W
Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide in pediatric and adult patients: comparison of efficacy and safety.
Verrotti A; Loiacono G; Pizzolorusso A; Parisi P; Bruni O; Luchetti A; Zamponi N; Cappanera S; Grosso S; Kluger G; Janello C; Franzoni E; Elia M; Spalice A; Coppola G; Striano P; Pavone P; Savasta S; Viri M; Romeo A; Aloisi P; Gobbi G; Ferretti A; Cusmai R; Curatolo P
Seizure; 2013 Apr; 22(3):210-6. PubMed ID: 23298605
[TBL] [Abstract][Full Text] [Related]
20. Early add-on lacosamide in a real-life setting: results of the REALLY study.
Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA;
Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
